BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 28822825)

  • 21. Revision surgery after interbody fusion with rhBMP-2: a cautionary tale for spine surgeons.
    Rodgers SD; Marascalchi BJ; Grobelny BT; Smith ML; Samadani U
    J Neurosurg Spine; 2013 Jun; 18(6):582-7. PubMed ID: 23560709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of RhBMP-2 in single-level transforaminal lumbar interbody fusion: a clinical and radiographic analysis.
    Rihn JA; Makda J; Hong J; Patel R; Hilibrand AS; Anderson DG; Vaccaro AR; Albert TJ
    Eur Spine J; 2009 Nov; 18(11):1629-36. PubMed ID: 19475434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploratory meta-analysis on dose-related efficacy and morbidity of bone morphogenetic protein in spinal arthrodesis surgery.
    Hofstetter CP; Hofer AS; Levi AD
    J Neurosurg Spine; 2016 Mar; 24(3):457-75. PubMed ID: 26613283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone morphogenetic protein use in spine surgery-complications and outcomes: a systematic review.
    Faundez A; Tournier C; Garcia M; Aunoble S; Le Huec JC
    Int Orthop; 2016 Jun; 40(6):1309-19. PubMed ID: 26961193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Use of Bone Morphogenetic Protein in Spinal Transforaminal Lumbar Interbody Fusion: Our Experience.
    Colom-Beauchamp E; Beaton-Comulada D; Rodriguez JA; Pérez-López JC; Montañez-Huertas J; Escobar-Medina E; Massanet-Vollrath J
    P R Health Sci J; 2017 Sep; 36(3):173-178. PubMed ID: 28915307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroforaminal chondrocyte metaplasia and clustering associated with recombinant bone morphogenetic protein-2 usage in transforaminal lumbar interbody fusion.
    Christensen TJ; Annis P; Hohl JB; Patel AA
    Spine J; 2014 Jun; 14(6):e23-8. PubMed ID: 24291359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2.
    Villavicencio AT; Burneikiene S; Nelson EL; Bulsara KR; Favors M; Thramann J
    J Neurosurg Spine; 2005 Dec; 3(6):436-43. PubMed ID: 16381205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant human bone morphogenetic protein-2-augmented transforaminal lumbar interbody fusion for the treatment of chronic low back pain secondary to the homogeneous diagnosis of discogenic pain syndrome: two-year outcomes.
    Corenman DS; Gillard DM; Dornan GJ; Strauch EL
    Spine (Phila Pa 1976); 2013 Sep; 38(20):E1269-77. PubMed ID: 23778368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse Events With the Use of rhBMP-2 in Thoracolumbar and Lumbar Spine Fusions: A 9-Year Institutional Analysis.
    Lubelski D; Abdullah KG; Steinmetz MP; Alvin MD; Nowacki AS; Chakka S; Benzel EC; Mroz TE
    J Spinal Disord Tech; 2015 Jun; 28(5):E277-83. PubMed ID: 23429306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human bone morphogenetic protein-2-induced radiculitis in elective minimally invasive transforaminal lumbar interbody fusions: a series review.
    Mindea SA; Shih P; Song JK
    Spine (Phila Pa 1976); 2009 Jun; 34(14):1480-4; discussion 1485. PubMed ID: 19525840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy of routine use of recombinant human bone morphogenetic protein-2 in occipitocervical and atlantoaxial fusions of the pediatric spine: a minimum of 12 months' follow-up with computed tomography.
    Sayama C; Hadley C; Monaco GN; Sen A; Brayton A; Briceño V; Tran BH; Ryan SL; Luerssen TG; Fulkerson D; Jea A
    J Neurosurg Pediatr; 2015 Jul; 16(1):14-20. PubMed ID: 25860982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The minimally effective dose of bone morphogenetic protein in posterior lumbar interbody fusion: a systematic review and meta-analysis.
    Lytle EJ; Lawless MH; Paik G; Tong D; Soo TM
    Spine J; 2020 Aug; 20(8):1286-1304. PubMed ID: 32339767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multilevel anterior cervical discectomy and fusion with and without rhBMP-2: a comparison of dysphagia rates and outcomes in 150 patients.
    Lu DC; Tumialán LM; Chou D
    J Neurosurg Spine; 2013 Jan; 18(1):43-9. PubMed ID: 23157278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004.
    Mummaneni PV; Pan J; Haid RW; Rodts GE
    J Neurosurg Spine; 2004 Jul; 1(1):19-23. PubMed ID: 15291015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes.
    Slosar PJ; Josey R; Reynolds J
    Spine J; 2007; 7(3):301-7. PubMed ID: 17482113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrograde ejaculation after anterior lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a 10-year cohort controlled study.
    Comer GC; Smith MW; Hurwitz EL; Mitsunaga KA; Kessler R; Carragee EJ
    Spine J; 2012 Oct; 12(10):881-90. PubMed ID: 23098617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjacent vertebral body osteolysis with bone morphogenetic protein use in transforaminal lumbar interbody fusion.
    Helgeson MD; Lehman RA; Patzkowski JC; Dmitriev AE; Rosner MK; Mack AW
    Spine J; 2011 Jun; 11(6):507-10. PubMed ID: 21729801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the efficacy and safety of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion to treat degenerative spinal disease: a protocol of prospective, randomized controlled, assessor-blinded, open-label, multicenter trial.
    Choi JY; Park HJ; Park SM; Kang CN; Song KS
    J Orthop Surg Res; 2022 Aug; 17(1):397. PubMed ID: 36045371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RhBMP-2 is superior to iliac crest bone graft for long fusions to the sacrum in adult spinal deformity: 4- to 14-year follow-up.
    Kim HJ; Buchowski JM; Zebala LP; Dickson DD; Koester L; Bridwell KH
    Spine (Phila Pa 1976); 2013 Jun; 38(14):1209-15. PubMed ID: 23392417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2).
    McClellan JW; Mulconrey DS; Forbes RJ; Fullmer N
    J Spinal Disord Tech; 2006 Oct; 19(7):483-6. PubMed ID: 17021411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.